Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

CYCLOPHOSPHAMIDE FOR INJECTION USP 2000 MG

CYCLOPHOSPHAMIDE : 2000 MG · DIN 02546744 · ANDONE PHARMACEUTICAL INC

Health Canada status: MARKETED

What is CYCLOPHOSPHAMIDE FOR INJECTION USP?

CYCLOPHOSPHAMIDE FOR INJECTION USP 2000 MG contains CYCLOPHOSPHAMIDE : 2000 MG. It is listed in the Health Canada Drug Product Database under DIN 02546744, held by ANDONE PHARMACEUTICAL INC, supplied as POWDER FOR SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 06-Jun-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02546744
Brand nameCYCLOPHOSPHAMIDE FOR INJECTION USP
Generic / active ingredientCYCLOPHOSPHAMIDE : 2000 MG
ManufacturerANDONE PHARMACEUTICAL INC
Strength2000 MG
Dosage formPOWDER FOR SOLUTION
Route of administrationINTRAVENOUS
SchedulePrescription
ATC codeL01AA01 CYCLOPHOSPHAMIDE
BiosimilarNo
Health Canada statusMARKETED
Status date06-Jun-2025

Is CYCLOPHOSPHAMIDE in shortage in Canada?

A Canadian shortage report is on file for this molecule: Active — reported by ANDONE PHARMACEUTICAL INC (Tier 3 shortage CYCLOPHOSPHAMIDE FOR INJECTION USP" aria-label="Anticipated Tier 3 shortage CYCLOPHOSPHAMIDE FOR INJECTI), last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for CYCLOPHOSPHAMIDE FOR INJECTION USP

What can be used instead?

Other Canadian products sharing ATC code L01AA01 CYCLOPHOSPHAMIDE. 12 of 28 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
CYCLOPHOSPHAMIDE FOR INJECTION USP1000 MGPOWDER FOR SOLUTIONMARCAN PHARMACEUTICALS INCMARKETEDDIN 02560216
CYCLOPHOSPHAMIDE FOR INJECTION USP1000 MGPOWDER FOR SOLUTIONANDONE PHARMACEUTICAL INCMARKETEDDIN 02546736
CYCLOPHOSPHAMIDE FOR INJECTION USP1000 MGInjectionSTERIMAX INCMARKETEDDIN 02547686
CYCLOPHOSPHAMIDE FOR INJECTION USP2000 MGPOWDER FOR SOLUTIONMARCAN PHARMACEUTICALS INCMARKETEDDIN 02560224
CYCLOPHOSPHAMIDE FOR INJECTION USP2000 MGPOWDER FOR SOLUTIONSTERIMAX INCMARKETEDDIN 02547694
PROCYTOX1000 MGPOWDER FOR SOLUTIONBAXTER CORPORATIONMARKETEDDIN 02241799
PROCYTOX200 MGPOWDER FOR SOLUTIONBAXTER CORPORATIONMARKETEDDIN 02241797
PROCYTOX2000 MGPOWDER FOR SOLUTIONBAXTER CORPORATIONMARKETEDDIN 02241800
PROCYTOX500 MGPOWDER FOR SOLUTIONBAXTER CORPORATIONMARKETEDDIN 02241798
PROCYTOX TAB 25MG25 MGTABLETBAXTER CORPORATIONMARKETEDDIN 02241795

Who else supplies CYCLOPHOSPHAMIDE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. CYCLOPHOSPHAMIDE appears in 28 registered pack listings across 5 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for CYCLOPHOSPHAMIDE FOR INJECTION USP

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for CYCLOPHOSPHAMIDE FOR INJECTION USP

Health Canada Drug Product Database (DPD), DIN 02546744. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.